https://laoshealthcarereview.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study Laos Healthcare Review en PressRelease 2026-04-18T10:00:00+00:00 Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://laoshealthcarereview.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude Laos Healthcare Review en PressRelease 2026-04-18T10:00:00+00:00 Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://laoshealthcarereview.com/article/906476191-vigosurge-claims-evaluated-analyzing-the-ingredients-benefits-side-effects-risk-and-customer-complaints Laos Healthcare Review en PressRelease 2026-04-18T08:34:39+00:00 VigoSurge Claims Evaluated: Analyzing the Ingredients' Benefits, Side Effects Risk and Customer Complaints https://zingfast.com/wp-content/uploads/2026/04/VigoSurge.jpg https://laoshealthcarereview.com/article/906451168-argenx-brings-neuromuscular-leadership-to-aan-2026-with-new-data-supporting-broader-vyvgart-use-across-mg-and-cidp Laos Healthcare Review en PressRelease 2026-04-18T05:00:00+00:00 argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://laoshealthcarereview.com/article/906425526-steel-flow-pro-claims-evaluated-analyzing-the-prostate-support-ingredients-side-effects-risk-and-hidden-complaints Laos Healthcare Review en PressRelease 2026-04-18T02:49:20+00:00 Steel Flow Pro Claims Evaluated: Analyzing the Prostate Support Ingredients, Side Effects Risk and Hidden Complaints https://zingfast.com/wp-content/uploads/2026/04/Steel-Flow-Pro.jpg https://laoshealthcarereview.com/article/906425477-vidacalm-claims-evaluated-analyzing-the-formula-s-ingredients-side-effects-risk-and-user-complaints Laos Healthcare Review en PressRelease 2026-04-18T01:30:16+00:00 VidaCalm Claims Evaluated: Analyzing the Formula's Ingredients, Side Effects Risk and User Complaints https://zingfast.com/wp-content/uploads/2026/04/VidaCalm.jpg https://laoshealthcarereview.com/article/906376671-iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Laos Healthcare Review en PressRelease 2026-04-17T21:15:00+00:00 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg https://laoshealthcarereview.com/article/906378346-keeps-hair-growth-product-claims-evaluated-topical-oral-rx-hair-loss-prescription-treatment-with-finasteride-dutasteride-minoxidil Laos Healthcare Review en PressRelease 2026-04-17T21:01:05+00:00 Keeps Hair Growth Product Claims Evaluated: Topical & Oral RX Hair Loss Prescription Treatment with Finasteride, Dutasteride & Minoxidil https://zingfast.com/wp-content/uploads/2026/04/Keeps-Hair-Growth.jpg https://laoshealthcarereview.com/article/906378336-boundless-bio-presents-preclinical-breast-cancer-data-from-its-oral-kinesin-degrader-program-at-2026-aacr-annual-meeting Laos Healthcare Review en PressRelease 2026-04-17T20:49:47+00:00 Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://laoshealthcarereview.com/article/906376058-celularity-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing Laos Healthcare Review en PressRelease 2026-04-17T20:35:00+00:00 Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing https://ml.globenewswire.com/media/ODBmYzBlZTctZGRjMC00YzIzLWEyYTEtODVjOGVkNjJlM2M4LTEyMTY1NjItMjAyNi0wNC0xNy1lbg==/tiny/Celularity-Inc-.png https://laoshealthcarereview.com/article/906376026-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Laos Healthcare Review en PressRelease 2026-04-17T20:15:00+00:00 Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://laoshealthcarereview.com/article/906375383-alx-oncology-reports-inducement-grant-as-permitted-by-the-nasdaq-listing-rules Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://laoshealthcarereview.com/article/906375426-theriva-biologics-announces-upcoming-presentation-of-additional-data-from-the-virage-phase-2b-clinical-trial-of-vcn-01-in-metastatic-pancreatic Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://laoshealthcarereview.com/article/906375629-4dmt-announces-new-employment-inducement-grants Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 4DMT Announces New Employment Inducement Grants https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://laoshealthcarereview.com/article/906375662-camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://laoshealthcarereview.com/article/906376371-oric-pharmaceuticals-presents-preclinical-data-to-support-the-potential-of-rinzimetostat-across-prostate-cancer-and-in-emerging-resistance-settings Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://laoshealthcarereview.com/article/906376697-pyxis-oncology-to-present-new-preclinical-data-showing-synergistic-anti-tumor-activity-in-a-hnscc-model-with-mamicvo-in-combination-with-anti-pd-1-at Laos Healthcare Review en PressRelease 2026-04-17T20:05:00+00:00 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://laoshealthcarereview.com/article/906377182-revolution-medicines-announces-closing-of-concurrent-upsized-public-offerings-with-aggregate-gross-proceeds-of-approximately-2-2-billion-including Laos Healthcare Review en PressRelease 2026-04-17T20:02:00+00:00 Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://laoshealthcarereview.com/article/906375334-adagene-presents-two-posters-at-aacr-2026-with-new-data-highlighting-muzastotug-s-potential-as-a-backbone-combination-therapy-for-multiple-tumor-types Laos Healthcare Review en PressRelease 2026-04-17T20:01:00+00:00 Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://laoshealthcarereview.com/article/906375816-xilio-therapeutics-announces-new-preclinical-data-at-aacr-annual-meeting-for-xtx601-a-masked-t-cell-engager-targeting-cldn18-2 Laos Healthcare Review en PressRelease 2026-04-17T20:01:00+00:00 Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://laoshealthcarereview.com/article/906376062-cardiff-oncology-presents-preclinical-data-on-its-plk1-inhibitor-onvansertib-in-combination-with-a-her2-targeted-adc-at-the-2026-aacr-annual-meeting Laos Healthcare Review en PressRelease 2026-04-17T20:01:00+00:00 Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://laoshealthcarereview.com/article/906376104-olema-oncology-announces-preclinical-data-for-palazestrant-and-op-3136-at-the-2026-aacr-annual-meeting Laos Healthcare Review en PressRelease 2026-04-17T20:01:00+00:00 Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://laoshealthcarereview.com/article/906376473-nexgel-moves-forward-shareholder-update-call-to-discuss-celularity-transaction-on-april-21st-at-4-30-p-m-et Laos Healthcare Review en PressRelease 2026-04-17T19:37:00+00:00 NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://laoshealthcarereview.com/article/906351275-zentalis-pharmaceuticals-to-present-azenosertib-preclinical-data-in-triple-negative-breast-cancer-and-real-world-analysis-of-unmet-need-in-cyclin Laos Healthcare Review en PressRelease 2026-04-17T19:15:00+00:00 Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://laoshealthcarereview.com/article/906350057-evaxion-s-ai-immunology-platform-demonstrates-86-vaccine-target-precision-in-phase-2-personalized-cancer-vaccine-trial Laos Healthcare Review en PressRelease 2026-04-17T19:10:00+00:00 Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://laoshealthcarereview.com/article/906352123-surgery-partners-inc-announces-first-quarter-2026-earnings-release-date-and-conference-call-details Laos Healthcare Review en PressRelease 2026-04-17T19:08:35+00:00 Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details https://ml.globenewswire.com/media/d0188456-e6d3-48f9-8479-b40422f00e4c/small/surgerypartnerslinear-1-jpg.jpg https://laoshealthcarereview.com/article/906352101-brazilian-wood-claims-evaluated-discover-the-male-enhancement-hardening-pill-truth-by-supernatural-man Laos Healthcare Review en PressRelease 2026-04-17T19:07:25+00:00 Brazilian Wood Claims Evaluated: Discover the Male Enhancement Hardening Pill Truth by SuperNatural Man https://zingfast.com/wp-content/uploads/2026/04/Brazilian-Wood.jpg https://laoshealthcarereview.com/article/906349949-prame-directed-cell-therapy-using-immatics-tcr-induces-deep-and-durable-remission-in-pediatric-patient-with-advanced-metastatic-nephroblastoma Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://laoshealthcarereview.com/article/906349959-asgard-therapeutics-to-present-preclinical-data-on-lead-asset-at-108-a-personalized-off-the-shelf-gene-therapy-at-aacr-annual-meeting-2026 Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026 https://ml-eu.globenewswire.com/media/5afbd1fa-9d4b-48d2-8f4f-d262d5a69053/small/asgard-tx-rgb-png.png https://laoshealthcarereview.com/article/906350035-new-data-demonstrates-the-unique-scalability-of-evaxion-s-ai-immunology-platform-in-glioblastoma Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://laoshealthcarereview.com/article/906350165-pheast-therapeutics-reports-initial-phase-1a-data-showing-early-clinical-activity-and-target-engagement-for-phst001-at-aacr-2026 Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026 https://ml.globenewswire.com/media/f27ab630-f23c-44f6-aae6-6fae240628af/small/pheast-logo-full-color-gradient-high-res-jpg.jpg https://laoshealthcarereview.com/article/906350188-zymeworks-presents-new-preclinical-data-at-aacr-2026-highlighting-broad-antibody-drug-conjugate-programs-including-novel-ras-targeting-platform Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://laoshealthcarereview.com/article/906350191-biolojic-design-presents-new-preclinical-data-for-bd200-a-first-in-class-multibody-drug-conjugate-targeting-trop-2-and-nectin-4-at-the-american Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting https://ml.globenewswire.com/media/5e7e1405-b691-484b-818b-1cb571d71d5c/small/biolojic-design-logo-vertical-color-resized-jpg.jpg https://laoshealthcarereview.com/article/906351284-mink-therapeutics-reports-phase-ii-data-on-immune-reprogramming-and-durable-survival-in-pd-1-refractory-gastroesophageal-cancer Laos Healthcare Review en PressRelease 2026-04-17T19:00:00+00:00 MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://laoshealthcarereview.com/article/906351536-jimstoppani-com-announces-summer-shred-challenge-with-25-000-grand-prize Laos Healthcare Review en PressRelease 2026-04-17T18:40:00+00:00 JimStoppani.com Announces Summer Shred Challenge with $25,000 Grand Prize https://pressranger.s3.us-west-1.amazonaws.com/3232316/Screenshot-2026-04-17-at-9.07.35%E2%80%AFAM.png https://laoshealthcarereview.com/article/906350253-opticore-eye-group-unveils-new-contact-lens-program-in-riverside-ca-for-2026 Laos Healthcare Review en PressRelease 2026-04-17T17:57:00+00:00 Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026 https://pressranger.s3.us-west-1.amazonaws.com/3232295/OpticoreSquareLogo.png https://laoshealthcarereview.com/article/906351097-rebalancing-agents-hympavzi-pfizer-qfitlia-sanofi-alhemo-novo-nordisk-gain-ground-in-hemophilia-as-physicians-navigate-access-barriers-and Laos Healthcare Review en PressRelease 2026-04-17T17:20:06+00:00 Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity https://ml.globenewswire.com/media/YjgxMGRkMDMtMDRjMC00ZTU5LTljMTUtODU4OTIyZTdlNzAxLTUwMDE1MTQyOC0yMDI2LTA0LTE3LWVu/tiny/Spherix-Global-Insights.png https://laoshealthcarereview.com/article/906351234-jellylean-claims-evaluated-discover-the-untold-truth-about-jelly-lean-gelatin-trick-gummies-recipe-for-weight-loss Laos Healthcare Review en PressRelease 2026-04-17T17:12:39+00:00 JellyLean Claims Evaluated: Discover the Untold Truth About Jelly Lean Gelatin Trick Gummies Recipe for Weight Loss https://zingfast.com/wp-content/uploads/2026/04/JellyLean.jpg https://laoshealthcarereview.com/article/906351224-pacemakers-market-to-reach-7-5-billion-by-2030-driven-by-expanding-clinical-indications-and-aging-demographics Laos Healthcare Review en PressRelease 2026-04-17T17:08:16+00:00 Pacemakers Market to Reach $7.5 Billion by 2030, Driven by Expanding Clinical Indications and Aging Demographics https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://laoshealthcarereview.com/article/906327205-yuhua-zhang-phd-named-chairholder-of-the-carolyn-and-chuck-miller-endowed-chair-for-vision-research Laos Healthcare Review en PressRelease 2026-04-17T16:00:00+00:00 Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research https://ml.globenewswire.com/media/ec2c0ef4-41b8-4d9c-b626-5afa01e65291/medium/yuhua-zhang-phd.jpg https://laoshealthcarereview.com/article/906311109-psyence-biomed-welcomes-u-s-executive-action-to-advance-research-into-ibogaine Laos Healthcare Review en PressRelease 2026-04-17T13:15:00+00:00 Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine https://ml.globenewswire.com/media/256a2527-4c30-46a1-a4d4-f37c89cfbff2/small/psyence-logo-jpg.jpg https://laoshealthcarereview.com/article/906308726-global-widget-celebrates-10-years-as-a-leader-in-premium-gummy-manufacturing Laos Healthcare Review en PressRelease 2026-04-17T13:00:00+00:00 Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing https://ml.globenewswire.com/media/56ac8ec6-8f17-4b3a-9f26-ae171e860afb/small/icn685386-icnglobal-widget-logo-jpg.jpg https://laoshealthcarereview.com/article/906310010-omada-health-helps-members-on-glp-1s-lose-more-fat-preserve-muscle-mass-and-improve-mental-health-new-study-finds Laos Healthcare Review en PressRelease 2026-04-17T13:00:00+00:00 Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://laoshealthcarereview.com/article/906304382-alps-group-appoints-former-ernst-young-partner-to-board-of-directors-strengthening-governance-and-capital-markets-oversight Laos Healthcare Review en PressRelease 2026-04-17T12:30:00+00:00 Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight https://ml.globenewswire.com/media/ce232220-dc3f-4308-a2b7-f695be7b9f0b/small/alps-global-holding-berhad-logo-01-png.png https://laoshealthcarereview.com/article/906308789-wilcrest-pharma-awarded-outsourced-compounded-preparations-agreement-with-premier-inc Laos Healthcare Review en PressRelease 2026-04-17T12:30:00+00:00 Wilcrest Pharma Awarded Outsourced Compounded Preparations Agreement with Premier, Inc. https://ml.globenewswire.com/media/ZDdjZmViMGQtOGMyZC00OWJmLWJiMjItNTY0ZTBiY2M4YTEyLTUwMDE2MTA5Ni0yMDI2LTA0LTE3LWVu/tiny/Wilcrest-Pharma.png https://laoshealthcarereview.com/article/906309029-intelligent-bio-solutions-advances-upcoming-fda-510-k-submission-successfully-completes-penetration-testing-with-no-major-vulnerabilities-identified Laos Healthcare Review en PressRelease 2026-04-17T12:30:00+00:00 Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://laoshealthcarereview.com/article/906310094-vaxart-announces-share-purchase-agreement-for-up-to-25-million-with-lincoln-park-capital Laos Healthcare Review en PressRelease 2026-04-17T12:30:00+00:00 Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://laoshealthcarereview.com/article/906311044-srx-health-solutions-and-emjx-issue-letter-to-shareholders-from-eric-m-jackson Laos Healthcare Review en PressRelease 2026-04-17T12:20:00+00:00 SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://laoshealthcarereview.com/article/906308984-first-steps-developmental-services-expands-services-in-woburn Laos Healthcare Review en PressRelease 2026-04-17T12:05:00+00:00 First Steps Developmental Services Expands Services in Woburn https://ml.globenewswire.com/media/ZjcwZDJhNDEtZjQ3Yi00MTFiLTg0MjYtOGUyZWRkZmE5NmY4LTEzMjI2NDctMjAyNi0wNC0xNy1lbg==/tiny/First-Steps-Developmental-Serv.png https://laoshealthcarereview.com/article/906308766-lexicon-to-present-data-at-the-american-academy-of-neurology-aan-annual-meeting Laos Healthcare Review en PressRelease 2026-04-17T12:00:00+00:00 Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://laoshealthcarereview.com/article/906309333-cogent-biosciences-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026 Laos Healthcare Review en PressRelease 2026-04-17T12:00:00+00:00 Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://laoshealthcarereview.com/article/906310108-lyra-therapeutics-inc-announces-intention-to-voluntarily-file-form-25-for-delisting-from-nasdaq-and-subsequent-deregistration-with-the-sec Laos Healthcare Review en PressRelease 2026-04-17T12:00:00+00:00 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC https://ml.globenewswire.com/media/0ad06b18-5b96-4274-8aa8-c57f0a1a8a87/small/lyra-logo-rgb-small-jpg.jpg https://laoshealthcarereview.com/article/906310195-medicus-pharma-submits-orphan-drug-designation-application-to-u-s-fda-for-skinject-in-gorlin-syndrome Laos Healthcare Review en PressRelease 2026-04-17T11:30:00+00:00 Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://laoshealthcarereview.com/article/906310710-repligen-opens-european-training-innovation-center-in-breda-expanding-global-customer-support-network Laos Healthcare Review en PressRelease 2026-04-17T11:30:00+00:00 Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://laoshealthcarereview.com/article/906310505-alterity-therapeutics-appoints-highly-experienced-biotech-executive-ann-cunningham-to-its-board-of-directors Laos Healthcare Review en PressRelease 2026-04-17T11:25:00+00:00 Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://laoshealthcarereview.com/article/906282258-bioxcel-therapeutics-announces-virtual-event-to-discuss-commercial-launch-plan-based-on-market-opportunity-assessment-for-igalmi-in-the-at-home Laos Healthcare Review en PressRelease 2026-04-17T11:00:00+00:00 BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting https://ml.globenewswire.com/media/63fea215-2cfc-4e2b-b169-43dcfff60b34/small/btai-logo-png-220x123-png.png https://laoshealthcarereview.com/article/906283356-upstream-bio-to-present-new-data-from-phase-2-vibrant-trial-of-verekitug-at-the-ats-2026-international-conference Laos Healthcare Review en PressRelease 2026-04-17T11:00:00+00:00 Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://laoshealthcarereview.com/article/906281138-yaqrit-phase-2a-data-clinical-consensus-boost-yaq007-and-yaq006-in-hepatic-encephalopathy Laos Healthcare Review en PressRelease 2026-04-17T10:59:53+00:00 Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy https://ml-eu.globenewswire.com/media/4e2e67d1-3239-456f-b007-beba28c06f71/small/logo-yaqrit-new-jpg.jpg https://laoshealthcarereview.com/article/906283909-invest-in-the-future-of-clean-energy-drinks-us-capital-global-securities-announces-10-million-offering-for-g-o-a-t-fuel Laos Healthcare Review en PressRelease 2026-04-17T10:43:41+00:00 Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel https://ml.globenewswire.com/media/ZDBkNzJlNTUtOGY1ZS00NTRhLWE4NjktYTdjMGM1ODIzZDUyLTExOTk2ODktMjAyNi0wNC0xNy1lbg==/tiny/US-Capital-Global.png https://laoshealthcarereview.com/article/906282624-kura-oncology-reports-darlifarnib-plus-cabozantinib-demonstrates-robust-activity-in-patients-with-clear-cell-renal-cell-carcinoma-previously-treated Laos Healthcare Review en PressRelease 2026-04-17T10:00:00+00:00 Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://laoshealthcarereview.com/article/906282818-immuron-double-digit-3q-sales-growth Laos Healthcare Review en PressRelease 2026-04-17T10:00:00+00:00 Immuron Double Digit 3Q Sales Growth https://ml.globenewswire.com/media/91da4c25-bccc-44c5-bc67-81258bbb1ba5/medium/global-year-to-date-net-sales-aud.jpg https://laoshealthcarereview.com/article/906260754-new-nordic-white-paper-reveals-systemic-barriers-preventing-women-from-reaching-leadership-roles Laos Healthcare Review en PressRelease 2026-04-17T08:00:00+00:00 New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles https://ml-eu.globenewswire.com/media/67f65e0c-87c4-4f95-92fa-0b52d6248335/medium/women-in-life-science-denmark-white-paper.jpg https://laoshealthcarereview.com/article/906260746-bioxodes-expands-clinical-advisory-board-shares-pivotal-trial-design-for-biox-101-in-intracerebral-hemorrhage Laos Healthcare Review en PressRelease 2026-04-17T06:30:00+00:00 Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://laoshealthcarereview.com/article/906240649-carbios-announces-fiscal-year-2025-financial-results Laos Healthcare Review en PressRelease 2026-04-17T05:45:00+00:00 Carbios announces fiscal-year 2025 financial results https://ml-eu.globenewswire.com/media/Mjk4MTcyMDgtZDQ2MS00ZGVkLTk4YjMtNDk2YjFjNTgyN2Y1LTEyMTU1MTctMjAyNi0wNC0xNy1lbg==/tiny/Carbios.png https://laoshealthcarereview.com/article/906240675-carbios-pr-sente-ses-r-sultats-annuels-2025 Laos Healthcare Review en PressRelease 2026-04-17T05:45:00+00:00 CARBIOS présente ses résultats annuels 2025 https://ml-eu.globenewswire.com/media/Mjk4MTcyMDgtZDQ2MS00ZGVkLTk4YjMtNDk2YjFjNTgyN2Y1LTEyMTU1MTctMjAyNi0wNC0xNy1mcg==/tiny/Carbios.png https://laoshealthcarereview.com/article/906218955-trevi-therapeutics-announces-pricing-of-150-million-underwritten-offering-of-common-stock Laos Healthcare Review en PressRelease 2026-04-17T02:42:00+00:00 Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://laoshealthcarereview.com/article/906198950-orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors Laos Healthcare Review en PressRelease 2026-04-17T00:10:00+00:00 OraSure Technologies Appoints John D. Bertrand to its Board of Directors https://ml.globenewswire.com/media/713ef28e-6d0b-4156-a92f-397061b474cf/small/oti-wordmark-png.png https://laoshealthcarereview.com/article/906198900-kailera-therapeutics-announces-pricing-of-initial-public-offering Laos Healthcare Review en PressRelease 2026-04-16T23:25:37+00:00 Kailera Therapeutics Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://laoshealthcarereview.com/article/906198660-picard-medical-syncardia-to-present-next-generation-total-artificial-heart-platform-at-ishlt-2026-in-toronto Laos Healthcare Review en PressRelease 2026-04-16T22:56:25+00:00 Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://laoshealthcarereview.com/article/906198752-extendicare-announces-voting-results-for-its-2026-annual-meeting-of-shareholders Laos Healthcare Review en PressRelease 2026-04-16T22:55:42+00:00 Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://laoshealthcarereview.com/article/906198499-jatt-ii-acquisition-corp-announces-pricing-of-60-000-000-initial-public-offering Laos Healthcare Review en PressRelease 2026-04-16T22:30:00+00:00 JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering https://ml.globenewswire.com/media/bdc8f213-b6bf-408e-bb10-139f74e91c08/small/jatt-ii-logo-png.png https://laoshealthcarereview.com/article/906182268-osteoshield-claims-evaluated-premium-quality-bone-density-support-formula-by-peak-health-research Laos Healthcare Review en PressRelease 2026-04-16T21:54:52+00:00 OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research https://zingfast.com/wp-content/uploads/2026/04/OsteoShield.jpg https://laoshealthcarereview.com/article/906181735-sanuwave-health-reports-preliminary-q1-2026-revenue-of-9-6-9-7-million-up-3-4-year-over-year Laos Healthcare Review en PressRelease 2026-04-16T21:00:00+00:00 Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://laoshealthcarereview.com/article/906181663-zorronet-delivers-98-success-in-israel-railways-pilot-awarded-framework-supply-agreement-for-ai-powered-detection-systems Laos Healthcare Review en PressRelease 2026-04-16T20:30:28+00:00 Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems https://ml.globenewswire.com/media/YTY5NmM2ZTgtNDhjNi00NGZmLTg3OTEtNGI5MmI3OTBiYjY2LTEzMjE4NzEtMjAyNi0wNC0xNi1lbg==/tiny/BiomX.png https://laoshealthcarereview.com/article/906180219-globus-medical-schedules-first-quarter-earnings-release-and-conference-call Laos Healthcare Review en PressRelease 2026-04-16T20:30:00+00:00 Globus Medical Schedules First Quarter Earnings Release and Conference Call https://ml.globenewswire.com/media/46f81a86-b794-42b0-bf72-63447eb13f53/small/gmlogo-2024-rgb-high-png.png https://laoshealthcarereview.com/article/906181600-vapofil-under-investigation-evaluating-the-vapor-rub-male-enhancement-honey-trick-claims Laos Healthcare Review en PressRelease 2026-04-16T20:24:47+00:00 VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims https://zingfast.com/wp-content/uploads/2026/04/VapoFil-Reviews.jpg https://laoshealthcarereview.com/article/906181421-spyre-therapeutics-inc-announces-closing-of-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for-gross Laos Healthcare Review en PressRelease 2026-04-16T20:15:00+00:00 Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://laoshealthcarereview.com/article/906180850-lifestance-to-host-first-quarter-2026-earnings-conference-call-on-may-7-2026 Laos Healthcare Review en PressRelease 2026-04-16T20:10:00+00:00 LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026 https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://laoshealthcarereview.com/article/906181413-trevi-therapeutics-announces-proposed-public-offering-of-common-stock Laos Healthcare Review en PressRelease 2026-04-16T20:08:00+00:00 Trevi Therapeutics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://laoshealthcarereview.com/article/906180185-pacbio-to-report-first-quarter-2026-financial-results-on-may-7-2026 Laos Healthcare Review en PressRelease 2026-04-16T20:05:00+00:00 PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://laoshealthcarereview.com/article/906180756-orthopediatrics-corp-to-report-first-quarter-financial-results-on-april-30-2026 Laos Healthcare Review en PressRelease 2026-04-16T20:05:00+00:00 OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026 https://ml.globenewswire.com/media/b05026f8-f835-4f46-a103-232db9c6c025/small/ortho-jpg.jpg https://laoshealthcarereview.com/article/906181098-emergent-biosolutions-successfully-refinances-term-loan-amends-asset-backed-loan-facility-and-increases-financial-flexibility Laos Healthcare Review en PressRelease 2026-04-16T20:05:00+00:00 Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://laoshealthcarereview.com/article/906181341-emergent-biosolutions-to-report-first-quarter-2026-financial-results-on-april-30-2026 Laos Healthcare Review en PressRelease 2026-04-16T20:05:00+00:00 Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://laoshealthcarereview.com/article/906180879-eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Laos Healthcare Review en PressRelease 2026-04-16T20:01:00+00:00 EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://laoshealthcarereview.com/article/906180932-allogene-therapeutics-announces-closing-of-200-4-million-public-offering-of-common-stock Laos Healthcare Review en PressRelease 2026-04-16T20:01:00+00:00 Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://laoshealthcarereview.com/article/906180905-terrascend-appoints-eric-jackson-as-chief-financial-officer Laos Healthcare Review en PressRelease 2026-04-16T20:00:00+00:00 TerrAscend Appoints Eric Jackson as Chief Financial Officer https://ml.globenewswire.com/media/3057ae6c-0bfe-49e0-90d4-66688bd859c8/small/picture1-png.png https://laoshealthcarereview.com/article/906159985-new-preclinical-data-on-stx-1-a-first-in-class-senolytic-adc-to-be-presented-at-aacr-2026 Laos Healthcare Review en PressRelease 2026-04-16T19:00:00+00:00 New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 https://ml-eu.globenewswire.com/media/759246b4-e94a-4390-9310-5992d066d0fd/small/starkage-2-1-png.png https://laoshealthcarereview.com/article/906161358-un-nouveau-partenariat-pour-acc-l-rer-la-recherche-innovante-dans-le-domaine-r-nal Laos Healthcare Review en PressRelease 2026-04-16T18:52:58+00:00 Un nouveau partenariat pour accélérer la recherche innovante dans le domaine rénal https://ml.globenewswire.com/media/YWQxMzkxODUtMGVmMC00MjViLWE0YzktNzYzMjU4ZTg0Nzc2LTUwMDE1OTA4My0yMDI2LTA0LTE2LWZy/tiny/The-Kidney-Foundation-of-Canad.png https://laoshealthcarereview.com/article/906161336-new-partnership-to-accelerate-innovation-in-kidney-research Laos Healthcare Review en PressRelease 2026-04-16T18:52:30+00:00 New Partnership to Accelerate Innovation in Kidney Research https://ml.globenewswire.com/media/72e7ad16-e1ed-44e9-a825-2f85325df0db/small/kf-logo-en-horz-jpg.jpg https://laoshealthcarereview.com/article/906159925-survey-of-correctional-facility-staff-monthly-opioid-treatment-shot-may-help-reduce-medication-misuse Laos Healthcare Review en PressRelease 2026-04-16T18:30:00+00:00 Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://laoshealthcarereview.com/article/906160482-new-national-platform-launches-to-bridge-the-gap-in-bereavement-care-introducing-griefsupportdirectory-com Laos Healthcare Review en PressRelease 2026-04-16T18:00:00+00:00 New National Platform Launches to Bridge the Gap in Bereavement Care: Introducing GriefSupportDirectory.com https://pressranger.s3.us-west-1.amazonaws.com/3231614/GriefSupportDirectoryLOGO1200x1200.jpg https://laoshealthcarereview.com/article/906159879-ab-science-provides-an-update-on-its-clinical-development-program Laos Healthcare Review en PressRelease 2026-04-16T17:20:13+00:00 AB Science provides an update on its clinical development program. https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://laoshealthcarereview.com/article/906159919-ab-science-fait-le-point-sur-son-programme-de-d-veloppement-clinique Laos Healthcare Review en PressRelease 2026-04-16T17:20:13+00:00 AB Science fait le point sur son programme de développement clinique https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://laoshealthcarereview.com/article/906160602-protoflow-claims-evaluated-the-high-potency-prostate-support-ingredients-for-day-night-relief Laos Healthcare Review en PressRelease 2026-04-16T17:19:59+00:00 ProtoFlow Claims Evaluated: The High Potency Prostate Support Ingredients for Day & Night Relief https://zingfast.com/wp-content/uploads/2026/04/ProtoFlow.jpg https://laoshealthcarereview.com/article/906144199-somnee-smart-sleep-headband-claims-evaluated-does-it-work-wearable-tech-for-restorative-rest-support Laos Healthcare Review en PressRelease 2026-04-16T17:16:16+00:00 Somnee Smart Sleep Headband Claims Evaluated: Does It Work? Wearable Tech for Restorative Rest Support https://zingfast.com/wp-content/uploads/2026/04/Somnee-Smart-Sleep-Headband.jpg https://laoshealthcarereview.com/article/906143976-wake-radiology-steps-up-to-the-plate-for-susan-g-komen-triangle-race-for-the-cure Laos Healthcare Review en PressRelease 2026-04-16T17:12:38+00:00 Wake Radiology "Steps Up to the Plate" for Susan G. Komen Triangle Race for the Cure https://ml.globenewswire.com/media/b40944d2-76ce-4a2f-8f95-3517f45fb57b/small/wr-logo-2024-png.png https://laoshealthcarereview.com/article/906144157-air-europa-enhances-safety-on-board-by-incorporating-specialized-medical-assistance-during-flights Laos Healthcare Review en PressRelease 2026-04-16T17:08:25+00:00 Air Europa Enhances Safety on Board by Incorporating Specialized Medical Assistance During Flights https://ml.globenewswire.com/media/ZjM3OTE4Y2MtZDViMy00ZTNiLTk3ZDYtNGExMDFmZGViYzExLTEyMzYwOTUtMjAyNi0wNC0xNi1lbg==/tiny/MedAire.png https://laoshealthcarereview.com/article/906139405-evaxion-concludes-annual-general-meeting Laos Healthcare Review en PressRelease 2026-04-16T15:30:00+00:00 Evaxion concludes Annual General Meeting https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://laoshealthcarereview.com/article/906142443-diverge-health-adds-oakland-southfield-physicians-in-michigan-to-list-of-physician-organization-partners Laos Healthcare Review en PressRelease 2026-04-16T15:18:50+00:00 Diverge Health adds Oakland Southfield Physicians in Michigan to List of Physician Organization Partners https://ml.globenewswire.com/media/1022b2c7-9fa0-4c07-b961-01fe372e9f57/small/simple-fc-4x-png.png https://laoshealthcarereview.com/article/906141067-the-infrastructure-play-hiding-in-plain-sight-across-cardiac-care Laos Healthcare Review en PressRelease 2026-04-16T15:00:00+00:00 The Infrastructure Play Hiding in Plain Sight Across Cardiac Care https://ml.globenewswire.com/media/fa80d6c4-97b0-465a-b7f0-f79df6f8bc19/small/screenshot-2025-12-09-at-4-53-16-am-1-png.png https://laoshealthcarereview.com/article/906141456-baylor-genetics-to-showcase-the-impact-of-early-genome-sequencing-at-annual-plugs-summit Laos Healthcare Review en PressRelease 2026-04-16T15:00:00+00:00 Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit https://ml.globenewswire.com/media/598c9f7b-cb07-4177-8fb3-646230113338/small/baylor-genetics-logo-oct-2025-for-wire-jpg.jpg https://laoshealthcarereview.com/article/906119748-purisaki-berberine-patches-2026-effective-weight-loss-for-women-lose-12-lbs-per-month-read-benefits-ingredients-side-effects-lunch-in-usa Laos Healthcare Review en PressRelease 2026-04-16T14:33:59+00:00 Purisaki Berberine Patches 2026 | Effective Weight Loss For Women Lose 12+ lbs per Month Read Benefits, Ingredients, Side Effects, Lunch in USA. https://ml-eu.globenewswire.com/Resource/Download/18cfe3d6-e158-41a8-94e9-e4c1461ac91f/purisaki-berberine-patches-side-effects.png https://laoshealthcarereview.com/article/906126405-confidential-care-to-provide-bravemind-virtual-reality-treatment-to-veterans Laos Healthcare Review en PressRelease 2026-04-16T14:31:40+00:00 Confidential Care to Provide BraveMind Virtual Reality Treatment to Veterans https://ml.globenewswire.com/media/23de679e-d628-4baa-ad17-b340e439a04a/small/soldierstrong-logo.jpg https://laoshealthcarereview.com/article/906119888-hearing-aids-market-set-to-reach-14-42-billion-by-2030-marketsandmarkets Laos Healthcare Review en PressRelease 2026-04-16T14:30:00+00:00 Hearing Aids Market Set to Reach $14.42 Billion by 2030 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG